CLX Medical, Inc. Asserts New Chairman Interview With questions about ...

Dimitri Nixon

14 August 2008

The focus of the interview is the company's latest statement that it has entered into an intent letter with ThyroTec, LLC to take ThyroTest, a fast thyroid exciting hormonescreening device used for the detection of hypothyroidism in adults, a frequent thyroid illness. In the interview, Ms Leonard debates the explanations that CLX focused ThyroTest for purchase, the dimensions of the potential market for the product, the US and worldwide distribution system for ThyroTest, and the competitive landscape for the product.

Ms Leonard also gives an outline of the company's progress since she was chosen to the position of Chairperson in 2007. ThyroTest is FDA cleared and in addition has achieved CLIA surrendered standing, so that the test can be administered in the more than 100000 CLIA relinquished doctors' offices in the U.S, in addition to in any non-waived laboratory. The easy fast diagnostic test is a qualitative measurement that authorizes consultants to screen adult patients for hypothyroidism in roughly 10 mins with a complete blood sample.

Hypothyroidism develops when the thyroid gland does not produce enough thyroid hormone to correctly control the body's metabolism. The incidence of hypothyroidism tends to extend with age, with older folk, particularly ladies, at highest risk . Common symptoms include weight gain, fatigue, mood swings, weakness, dry and coarse skin and hair, hair loss, depression, decreased libido, difficulty swallowing, increased cholesterol, heavy or irregular periods or difficulty getting pregnant. Roughly 120 mill thyroid-related lab tests are performed in the US every year. At a computed average value of $40 per test, the US market is now priced at just about $5 bill. Roughly forty five m. of those tests are conducted to diagnose thyroid dysfunction. CLX believes that ThyroTest is an acceptable, inexpensive first-step for those forty five mill diagnostic TSH tests. This current US market opportunity is amplified by the CLIA surrendered standing, which makes the chance to meet Yankee Thyroid organisation suggestions for screening each individual at age 35 and each 5 years afterward a fact. CLX recently revealed an intent letter to take ThyroTest, a quick thyroid exciting hormone ( TSH ) screening device used for the detection of hypothyroidism in adults, a typical thyroid illness. CLX Medical is targeted on the successful worldwide distribution of these and any extra products it may take or license. There may be no guarantee that such statements will prove correct. Tangible results and future events could differ materially from those forecasted in such statements depending on several factors.